Related Experiment Video
Updated: Mar 14, 2026

A Semi-Automated and Reproducible Biological-Based Method to Quantify Calcium Deposition In Vitro
Published on: June 2, 2022
Development and Validation of a Novel Laboratory-Specific Correction Equation for Total Serum Calcium and Its
Yoshitsugu Obi1, Danh V Nguyen2,3, Elani Streja1
1Harold Simmons Center for Kidney Disease Research and Epidemiology, Division of Nephrology and Hypertension, University of California Irvine, School of Medicine, Orange, CA, USA.
Insights
A new equation accurately identifies hidden hypercalcemia in hemodialysis patients, improving mortality risk prediction compared to standard methods. This helps pinpoint at-risk individuals more effectively.
Area of Science:
- Nephrology
- Clinical Chemistry
- Biostatistics
Background:
- Conventional albumin-corrected calcium measurements are unreliable for assessing ionized calcium levels.
- Hidden hypercalcemia (normal total calcium, high ionized calcium) is linked to increased mortality in hemodialysis patients.
Purpose of the Study:
- To develop and validate a novel, laboratory-specific equation for predicting ionized calcium in hemodialysis patients.
- To compare the performance of the novel equation against the conventional method in identifying hypercalcemia and predicting mortality.
Main Methods:
- A novel prediction equation using total calcium, albumin, and phosphorus was derived from a US national cohort of hemodialysis patients.
- The equation was validated in a separate cohort, and its performance was compared to the conventional equation using correlation with intact parathyroid hormone, sensitivity, and specificity.
- Survival analysis was conducted on a large cohort of incident hemodialysis patients to assess mortality risk based on calcium levels determined by both equations.
Main Results:
- The novel equation demonstrated superior accuracy (adjusted R² = 0.80 vs. 0.71) in predicting ionized calcium compared to the conventional equation.
- It showed a stronger correlation with intact parathyroid hormone and higher sensitivity for detecting ionized hypercalcemia.
- The novel equation identified a trend toward higher mortality risk in patients with high-normal calcium levels, which was not apparent with the conventional equation.
Conclusions:
- A novel laboratory-specific equation significantly improves the assessment of hidden hypercalcemia in hemodialysis patients.
- This new equation offers better identification of patients at higher risk for mortality compared to conventional methods.
- The findings support the use of the novel equation for more accurate calcium management and risk stratification in hemodialysis populations.
Abstract:
Conventional albumin-corrected calcium is inaccurate in predicting ionized calcium, and hidden hypercalcemia, characterized as high ionized calcium with normal total calcium, is associated with higher mortality in hemodialysis patients. By using a national cohort of hemodialysis patients in the Unites States, a novel laboratory-specific prediction equation composed of total calcium, albumin, and phosphorus was derived from 242 patients in the South Atlantic division (adjusted R2 = 0.80 versus 0.71 for the conventional equation) and then validated among 566 patients in the other divisions (adjusted R2 = 0.79 versus 0.68 for the conventional equation). Compared with the conventional equation, the novel equation showed a greater correlation with intact parathyroid hormone. Its relative performance against the conventional equation was consistent across subgroups based on medications related to calcium metabolism. The novel equation also had a higher sensitivity (57% versus 34%) and an equivalent specificity (99% versus 100%) against ionized hypercalcemia at a cut-off value of 10.2 mg/dL. Sensitivity and specificity at 9.4 mg/dL was 94% and 76% (versus 87% and 82% for the conventional equation), respectively. A survival analysis in 87,779 incident hemodialysis patients showed that among patients who were categorized as having a high-normal calcium status (ie, >9.4 to 10.2 mg/dL) by the conventional equation, there appeared a trend toward higher adjusted mortality risk across higher calcium status defined according to the novel equation. Meanwhile, the mortality risk was consistent across calcium strata defined according to the conventional equation within the categories defined by the novel equation. In conclusion, in comparison to the conventional equation, a novel laboratory-specific correction equation derived for correction of total calcium performs significantly better in ascertaining hidden hypercalcemia in hemodialysis patients, and aids in identifying patients at higher risk for mortality. © 2016 American Society for Bone and Mineral Research.
Related Concept Videos
Drug Dosing in Renal Diseases: Estimation of Glomerular Filtration Rate Based on Serum Creatinine Concentration
Drug Dosing in Renal Diseases: Dose Adjustments Based on Drug Clearance and Elimination Rate Constant
Chronic Kidney Disease III: Interprofessional Care
Drug Dosing in Renal Diseases: Measurement of Serum Creatinine Concentration and Clearance
Skeleton and Calcium Homeostasis
Hemodialysis III: Nursing Management

